Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 8/20 | 0.77 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.77 |
| ▸ | LMNA | P02545 | 5/20 | 0.64 |
| ▸ | MAPT | P10636 | 4/20 | 0.64 |
| ▸ | HPGD | P15428 | 4/20 | 0.61 |
| ▸ | GLA | P06280 | 2/20 | 0.61 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.61 |
| ▸ | NUDT1 | P36639 | 3/20 | 0.60 |
| ▸ | ADORA2A | P29274 | 2/20 | 0.60 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.55 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.55 |
| ▸ | MEN1 | O00255 | 3/20 | 0.55 |
| ▸ | GAA | P10253 | 3/20 | 0.55 |
| ▸ | PKM | P14618 | 1/20 | 0.53 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.53 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.52 |
| ▸ | HTT | P42858 | 1/20 | 0.52 |
| ▸ | ATM | Q13315 | 1/20 | 0.51 |
| ▸ | RAD52 | P43351 | 1/20 | 0.50 |
| ▸ | MAOA | P21397 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL808191 | 0.96 | KDM4E (0.77) | KDM4EALDH1A1LMNAMAPTHPGD | |
| SCHEMBL17286874 | 0.96 | KDM4E (0.77) | KDM4EALDH1A1LMNAMAPTHPGD | |
| Hydrochloric Acid SCHEMBL5803147 | 0.96 | KDM4E (0.72) | KDM4EALDH1A1LMNAMAPTHPGD | |
| SCHEMBL5803149 | 0.94 | KDM4E (0.70) | KDM4EALDH1A1LMNAMAPTHPGD | |
| SCHEMBL4087331 | 0.90 | KDM4E (0.75) | KDM4EALDH1A1LMNAMAPTHPGD | |
| SCHEMBL17299607 | 0.89 | KDM4E (0.69) | KDM4EALDH1A1LMNAMAPTHPGD | |
| SCHEMBL20258996 | 0.89 | ALDH1A1 (0.68) | KDM4EALDH1A1LMNAMAPTHPGD | |
| SCHEMBL15810834 | 0.89 | ALDH1A1 (0.63) | KDM4EALDH1A1LMNAMAPTHPGD | |
| SCHEMBL17299602 | 0.88 | KDM4E (0.67) | KDM4EALDH1A1LMNAMAPTHPGD | |
| SCHEMBL22607015 | 0.87 | KDM4E (0.71) | KDM4EALDH1A1LMNAMAPTHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1209 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109485610-B | Method for synthesizing 2-chloro-4-phenylquinazoline by one-pot method | 安徽秀朗新材料科技有限公司 | 2020-07-24 | — | — | CN | claimed |
| CN-109485610-A | The method of the chloro- 4- phenylquinazoline of one pot process 2- | 安徽秀朗新材料科技有限公司 | 2019-03-19 | — | — | CN | claimed |
| CN-105198806-B | A kind of method using aromatic amine, diketone synthesis of quinoline derivatives | 南阳师范学院 | 2017-11-21 | — | — | CN | claimed |
| CN-107082765-A | A kind of synthetic method of the phenylquinazoline of 2 chlorine 4 | 常州大学 | 2017-08-22 | — | — | CN | claimed |
| CN-106892925-A | A kind of OLED material based on pyrrolo carbazole derivatives and preparation method thereof | 西安瑞联新材料股份有限公司 | 2017-06-27 | — | — | CN | claimed |
| EP-0536360-A4 | TOPICAL TREATMENT OF ACNE | — | 1993-08-04 | — | — | EP | claimed |
| EP-0536360-A1 | TOPICAL TREATMENT OF ACNE | BLOOM, Leonard (US) | 1993-04-14 | — | — | EP | claimed |
| WO-1992015299-A1 | TOPICAL TREATMENT OF ACNE | BLOOM, LEONARD (US) | 1992-09-17 | — | — | WO | claimed |
| JP-56092875-A | — | — | None | — | — | JP | disclosed |
| US-12637466-B2 | Benzocarbazole-based compound and organic light-emitting device comprising same | LG CHEM, LTD. (KR) | 2026-05-26 | — | — | US | disclosed |
| CN-114763349-B | Organic compound, application and preparation method thereof and organic electroluminescent device using same | 北京鼎材科技股份有限公司 | 2026-05-22 | — | — | CN | disclosed |
| US-20260082809-A1 | HETEROCYCLIC COMPOUND, ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME AND COMPOSITION FOR ORGANIC MATERIAL LAYER | LT MATERIALS CO LTD (KR) | 2026-03-19 | — | — | US | disclosed |
| US-12459946-B2 | Organic host materials for electroluminescent devices | UNIVERSAL DISPLAY CORPORATION (US) | 2025-11-04 | — | — | US | disclosed |
| US-12415949-B2 | Compound, organic electroluminescent device, and display device | SK INC. (KR) | 2025-09-16 | — | — | US | disclosed |
| WO-1992015299-A1 | TOPICAL TREATMENT OF ACNE | BLOOM, LEONARD (US) | 1992-09-17 | — | — | WO | disclosed |
| WO-1992001675-A2 | SUBSTITUTED BICYCLIC BIS-ARYL COMPOUNDS EXHIBITING SELECTIVE LEUKOTRIENE B4 ANTAGONIST ACTIVITY, THEIR PREPARATION AND USE IN PHARMACEUTICAL COMPOSITIONS | RHONE-POULENC RORER S.A. (FR) | 1992-02-06 | — | — | WO | disclosed |
| US-5011997-A | Process for bis(4-aminophenyl)hexafluoropropane | HOECHST CELANESE CORP. (US) | 1991-04-30 | — | — | US | disclosed |
| US-4906741-A | Azo dimers containing the hexafluoroisopropylidene group | HOECHST CELANESE CORPORATION (US) | 1990-03-06 | — | — | US | disclosed |
| EP-0311028-A2 | A process for bis (4-aminophenyl) hexafluoropropane | HOECHST CELANESE CORPORATION (US) | 1989-04-12 | — | — | EP | disclosed |
| JP-S5692875-A | 2-AMINOQUINAZOLINE DERIVATIVE | DAINIPPON PHARMACEUT CO LTD | 1981-07-27 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12415949-B2 | Compound, organic electroluminescent device, and display device | L1CAM, EML4, OCIAD2 | KDM4E 3234/4885ALDH1A1 184/4885LMNA 1645/4885 |
| US-12459946-B2 | Organic host materials for electroluminescent devices | RPS4X, RPS4Y1, MRPS34 | KDM4E 954/4885ALDH1A1 2022/4885LMNA 2768/4885 |
| US-12637466-B2 | Benzocarbazole-based compound and organic light-emitting device comprising same | CYP1A1, CYP2E1, CYP3A4 | KDM4E 1432/4885ALDH1A1 341/4885LMNA 549/4885 |
| US-20260082809-A1 | HETEROCYCLIC COMPOUND, ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME AND COMPOSITION FOR ORGANIC MATERIAL LAYER | CRY1, CRY2, CYC1 | KDM4E 3952/4885ALDH1A1 1460/4885LMNA 908/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.